40 results
DEFA14A
ACGN
Aceragen Inc
30 Sep 22
Additional proxy soliciting materials
4:18pm
-regulatory organization (including Nasdaq).
“Hazardous Materials” means any pollutant, chemical, substance and any toxic, infectious, carcinogenic
8-K
EX-2.1
eqxvjf6
30 Sep 22
Entry into a Material Definitive Agreement
4:15pm
DEFA14A
EX-99.2
86f1q
28 Sep 22
Additional proxy soliciting materials
4:59pm
8-K
EX-99.2
feumyf199lf 96cxf
28 Sep 22
Idera Pharmaceuticals Acquires Aceragen
4:29pm
8-K
EX-10.1
yvypsx
15 Jul 20
Idera Pharmaceuticals Announces Private Placement of up to $20.0 Million
8:15am
8-K
EX-10.1
1g81xy
7 Apr 20
Idera Pharmaceuticals Announces Private Placement of up to $20.7 Million
4:30pm
8-K
EX-10.1
4z1iqwgar7e
23 Dec 19
Idera Pharmaceuticals Announces Private Placement Up To $97.7 Million
4:01pm
8-K
EX-1.1
bl3d1r4xw0fzt
26 Nov 18
Entry into a Material Definitive Agreement
5:25pm
425
EX-2.1
e3m1pf68ca
22 Jan 18
Business combination disclosure
12:00am
425
EX-2.1
5tdlyifinx i0d
22 Jan 18
Business combination disclosure
12:00am